United States · Investor

Triathlon Medical Venture Partners

Last cheque observed Jan 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries ASeries CCloud ComputingSoftwareLife Science

Cheques on record
0%of best year0cheques in 12 months, 23 on record
Since the last cheque4304days00hrs00min00sec
Median round$23MRounds led0 of 23Exits2 from the portfolioMostly inUnited States, 91%
Pitch Triathlon Medical Venture Partners

Triathlon Medical Venture Partners highlights

  1. 01

    23 rounds on record

  2. 02

    Mostly Series B and Series A: 50% of its rounds

  3. 03

    2 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
Cloud ComputingSoftwareLife Science
Based in
Cincinnati, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first23 appearances

  1. 2015

    1 round

  2. Jan
    CoLucid PharmaceuticalsSeries C · US$37MWith 7 others
  3. 2014

    1 round

  4. Apr
    Aerpio TherapeuticsVenture · US$22MWith 4 others
  5. 2013

    2 rounds

  6. Nov
    Aerpio TherapeuticsSeries A · US · finsmes.com$9.0MWith 4 others
  7. Jun
    Akebia TherapeuticsSeries C · US · finsmes.com$41MWith 8 others
  8. 2012

    5 rounds

  9. Oct
    Tolera TherapeuticsSeries B · US · prnewswire.com$5.5MWith 2 others
  10. Aug
    Aerpio TherapeuticsSeries A · US · finsmes.com$27MWith 6 others
  11. Jul
    Juventas TherapeuticsSeries B · US · finsmes.com$22MWith 7 others
  12. May
    MitralignSeries D · US · finsmes.com$35MWith 5 others
  13. Jan
    Akebia TherapeuticsSeries B · US · finsmes.com$4.1MWith 7 others
  14. 2011

    2 rounds

  15. Aug
    CoLucid PharmaceuticalsSeries B · US · prnewswire.com$7.5MWith 4 others
  16. Apr
    Akebia TherapeuticsSeries B · US · akebia.com$22MWith 6 others
  17. 2010

    1 round

  18. Jan
    EndocyteSeries C · US · onbiovc.com$26MWith 4 others
  19. 2009

    2 rounds

  20. Sept
    Akebia TherapeuticsSeries A · US · onbiovc.com$16MWith 4 others
  21. Mar
    BioVexSeries F · GB · fiercebiotech.com$40MWith 7 others
  22. 2008

    4 rounds

  23. Jul
    CellerationSeries D · US$30MWith 10 others
  24. Jul
    CoLucid PharmaceuticalsSeries B · US$25MWith 4 others
  25. Jun
    Tolera TherapeuticsSeries A · USUndisclosedWith 2 others
  26. Jan
    CS-KeysSeries A · US · ceresventurefund.com$6.3MWith 4 others
  27. 2007

    3 rounds

  28. Dec
    MitralignSeries C · US$24MWith 7 others
  29. Nov
    BioVexSeries E · GB$35MWith 10 others
  30. Mar
    EndocyteSeries C · US$15MWith 5 others
  31. 2006

    2 rounds

  32. Dec
    HydrocisionVenture · US$13MWith 2 others
  33. Nov
    EndocyteSeries D · US$30MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

CellerationBought by Alliqua$30MFeb 2015
BioVexBought by Amgen$1.0BJan 2011

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Triathlon Medical Venture Partners. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Triathlon Medical Venture Partners

What does Triathlon Medical Venture Partners invest in?

Triathlon Medical Venture Partners invests most often at Series B and Series A (50% of the rounds on record), in sectors such as Cloud Computing, Software and Life Science.

How active is Triathlon Medical Venture Partners?

23 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2015.

How big are Triathlon Medical Venture Partners's cheques?

The median round it joins is $23M.

Does Triathlon Medical Venture Partners lead rounds?

Rarely, if at all: none of its 23 investments on record names it as the lead.

Where does Triathlon Medical Venture Partners invest?

Most of the companies it backs are in the United States (91%) and the United Kingdom (9%).

Is Triathlon Medical Venture Partners investing now?

No investments in the last 12 months; the latest was in Jan 2015.

Who does Triathlon Medical Venture Partners invest alongside?

Most often Athenian Venture Partners (6 rounds together), Kearny Venture Partners (6 rounds together) and Novartis Venture Fund (6 rounds together).

What kind of investor is Triathlon Medical Venture Partners?

Triathlon Medical Venture Partners is a growth equity firm based in Cincinnati, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it